Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1968 Sep;34(1):141–147. doi: 10.1111/j.1476-5381.1968.tb07957.x

The effects of some β-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart

J W Foo, Alison Jowett, Anne Stafford
PMCID: PMC1703465  PMID: 4386370

Abstract

1. The potencies of some β-adrenoreceptor blocking drugs in reducing noradrenaline uptake by the isolated heart were compared with their potencies in reducing the release of noradrenaline from the heart by tyramine.

2. Of the drugs tested, propranolol, pronethalol and dichloroisoprenaline were the most potent in blocking uptake and release of noradrenaline, although none was at potent as cocaine; MJ 1999 and I.C.I. 50172 were only weakly effective.

3. Pronethalol and dichloroisoprenaline each reduced release of noradrenaline by tyramine in the concentration range (10-7-10-6M) where blockade of responses to tyramine was apparent; with these drugs both reduction of noradrenaline release and β-receptor blockade contribute to the reduction in responses to tyramine.

4. Potency of β-receptor blocking drugs in reducing noradrenaline uptake is unrelated to potency in blocking β-receptors; Kö 592 blocks β-receptors without affecting noradrenaline uptake.

Full text

PDF
143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTON A. H., SAYRE D. F. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 1962 Dec;138:360–375. [PubMed] [Google Scholar]
  2. Aramendía P., Kaumann A. J. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999). J Pharmacol Exp Ther. 1967 Feb;155(2):259–266. [PubMed] [Google Scholar]
  3. BENFEY B. G., VARMA D. R. INHIBITION OF SYMPATHOMIMETIC EFFECTS ON THE HEART. Br J Pharmacol Chemother. 1964 Oct;23:399–404. doi: 10.1111/j.1476-5381.1964.tb01596.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. De la Lande I. S., Harvey J. A. A new and sensitive bioassay for catecholamines. J Pharm Pharmacol. 1965 Sep;17(9):589–593. doi: 10.1111/j.2042-7158.1965.tb07727.x. [DOI] [PubMed] [Google Scholar]
  5. FARRANT J., HARVEY J. A., PENNEFATHER J. N. THE INFLUENCE OF PHENOXYBENZAMINE ON THE STORAGE OF NORADRENALINE IN RAT AND CAT TISSUES. Br J Pharmacol Chemother. 1964 Feb;22:104–112. doi: 10.1111/j.1476-5381.1964.tb01547.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. LINDMAR R., MUSCHOLL E. DIE WIRKUNG VON PHARMAKA AUF DIE ELIMINATION VON NORADRENALIN AUS DER PERFUSIONSFLUESSIGKEIT UND DIE NORADRENALINEUFNAHME IN DAS ISOLIERTE HERZ. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964 Jul 28;247:469–492. doi: 10.1007/BF00329896. [DOI] [PubMed] [Google Scholar]
  7. MACMILLAN W. H. A hypothesis concerning the effect of cocaine on the action of sympathomimetic amines. Br J Pharmacol Chemother. 1959 Sep;14:385–391. doi: 10.1111/j.1476-5381.1959.tb00263.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MCEWEN L. M. The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain. J Physiol. 1956 Mar 28;131(3):678–689. doi: 10.1113/jphysiol.1956.sp005493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Westfall T. C. Effect of beta adrenergic blocking agents on the noradrenaline content of rat heart before and after noradrenaline infusion. Eur J Pharmacol. 1967 Dec;2(3):163–168. doi: 10.1016/0014-2999(67)90081-7. [DOI] [PubMed] [Google Scholar]
  10. von Euler U. S. Release and uptake of noradrenaline in adrenergic nerve granules. Acta Physiol Scand. 1966 Jul-Aug;67(3):430–440. doi: 10.1111/j.1748-1716.1966.tb03330.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES